Citation Information :
Angadi VM. Methylene Blue in Septic Shock—A Novel Weapon in Our Arsenal: Are Utility Studies Highlighting its Futility?. Indian J Crit Care Med 2024; 28 (1):89-89.
Rajbanshi LK, Bajracharya A, Arjyal B, Devkota D. Can use of intravenous methylene blue improve the hemodynamics and outcome of the patients with refractory septic shock? An observational study. Indian J Crit Care Med 2023;27(9):669–674. DOI: 10.5005/jp-journals-10071-24535.
Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress. J Intensive Care Med 2009;24(5):293–316. DOI: 10.1177/0885066609340519.
Zhong L, Ji XW, Wang HL, Zhao GM, Zhou Q, Xie B. Non-catecholamine vasopressors in the treatment of adult patients with septic shock – Evidence from meta-analysis and trial sequential analysis of randomized clinical trials. J Intensive Care 2020;8(1):83. DOI: 10.1186/s40560-020-00500-0.